At a glance
- Originator Daiichi Pharmaceutical
- Developer Daiichi Pharmaceutical; Nonindustrial sources
- Class Antivirals
- Mechanism of Action Transactivator transcription protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 19 Apr 2001 Preclinical development for HIV-1 infections in Japan (Unknown route)